TFEB Participates in the Aβ-Induced Pathogenesis of Alzheimer's Disease by Regulating the Autophagy-Lysosome Pathway

DNA and Cell Biology

Volumn 34, Issue 11, 2015, Pages 661-668

  Zhang, Yi Dan ^a   Zhao, Jian Jun ^a  

^a CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CARBONYL DERIVATIVE; CATHEPSIN D; CELL PROTEIN; LC3 II PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MALONALDEHYDE; PROTEIN P52; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EB; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; PEPTIDE FRAGMENT; TCFEB PROTEIN, MOUSE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYSOSOME; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; CELL LINE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; PHAGOSOME; PHYSIOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; AUTOPHAGY; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BEHAVIOR, ANIMAL; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; LYSOSOMES; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHAGOSOMES;

EID: 84946748901     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2014.2738     Document Type: Article

References (30)

1. Anekonda, T. S., Wadsworth, T. L., Sabin, R., Frahler, K., Harris, C., Petriko, B., et al. (2011). Phytic acid as a potential treatment for Alzheimer's pathology: evidence from animal and in vitro models. J Alzheimers Dis 23, 21-35.
2. Bonda, D. J., Lee, H.-P., Lee, H.-G., Friedlich, A. L., Perry, G., Zhu, X., et al. (2010). Novel therapeutics for Alzheimer's disease: An update. Curr Opin Drug Discov Dev 13, 235.
3. Chu, C., Zhang, X., Ma, W., Li, L., Wang, W., Shang, L., et al. (2013). Induction of autophagy by a novel small molecule improves abeta pathology and ameliorates cognitive deficits. PLoS One 8, e65367.
4. Fortunato, F., and Kroemer, G. (2009). Impaired autophagosomelysosome fusion in the pathogenesis of pancreatitis. Autophagy 5, 850-853.
5. Hebert, S. S., Horre, K., Nicolai, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., et al. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A 105, 6415-6420.
6. Hettiarachchi, N., Dallas, M., Al-Owais, M., Griffiths, H., Hooper, N., Scragg, J., et al. (2014). Heme oxygenase-1 protects against Alzheimer's amyloid-beta(1-42)-induced toxicity via carbon monoxide production. Cell Death Dis 5, e1569.
7. Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., et al. (2004). Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13, 159-170.
8. Lee, S.-J., Liyanage, U., Bickel, P. E., Xia, W., Lansbury, P. T., and Kosik, K. S. (1998). A detergent-insoluble membrance compartment contains Ab in vivo. Nat Med 4, 730-734.
9. Ling, D., Magallanes, M., and Salvaterra, P. M. (2014). Accumulation of amyloid-likeAbeta1-42 inAEL(autophagy-endosomallysosomal) vesicles: Potential implications for plaque biogenesis. ASN Neuro 6, pii: e00139, doi: 10. 1042/AN20130044.
10. Luo, S., and Wehr, N. B. (2009). Protein carbonylation: Avoiding pitfalls in the 2, 4-dinitrophenylhydrazine assay. Redox Rep 14, 159-166.
11. Majumder, S., Richardson, A., Strong, R., and Oddo, S. (2011). Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS One 6, e25416.
12. Mizushima, N., Levine, B., Cuervo, A. M., and Klionsky, D. J. (2008). Autophagy fights disease through cellular selfdigestion. Nature 451, 1069-1075.
13. Nixon, R. A. (2007). Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120, 4081-4091.
14. Nixon, R. A., and Yang, D.-S. (2011). Autophagy failure in Alzheimer's disease-locating the primary defect. Neurobiol Dis 43, 38-45.
15. Patsoukis, N., and Georgiou, C. D. (2004). Determination of the thiol redox state of organisms: new oxidative stress indicators. Anal Bioanal Chem 378, 1783-1792.
16. Polito, V. A., Li, H., Martini-Stoica, H., Wang, B., Yang, L., Xu, Y., et al. (2014). Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol Med 6, 1142-1160.
17. Roczniak-Ferguson, A., Petit, C. S., Froehlich, F., Qian, S., Ky, J., Angarola, B., et al. (2012). The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal 5, ra42.
18. Satoh, J. (2012). Molecular network of microRNA targets in Alzheimer's disease brains. Exp Neurol 235, 436-446.
19. Settembre, C., Di Malta, C., Polito, V. A., Garcia Arencibia, M., Vetrini, F., Erdin, S., et al. (2011). TFEB links autophagy to lysosomal biogenesis. Science 332, 1429-1433.
20. Settembre, C., Zoncu, R., Medina, D. L., Vetrini, F., Erdin, S., Huynh, T., et al. (2012). A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 31, 1095-1108.
21. Turunc Bayrakdar, E., Uyanikgil, Y., Kanit, L., Koylu, E., and Yalcin, A. (2014). Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Abeta(1-42)-induced rat model of Alzheimer's disease. Free Radic Res 48, 146-158.
22. Wang, W. X., Huang, Q., Hu, Y., Stromberg, A. J., and Nelson, P. T. (2011). Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 121, 193-205.
23. Wang, W.-X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., et al. (2008). The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of b-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28, 1213-1223.
24. Weihl, C. C. (2013). Monitoring autophagy in the treatment of protein aggregate diseases: steps toward identifying autophagic biomarkers. Neurotherapeutics 10, 383-390.
25. Wong, E., and Cuervo, A. M. (2010). Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 13, 805-811.
26. Xiao, Q., Yan, P., Ma, X., Liu, H., Perez, R., Zhu, A., et al. (2014). Enhancing astrocytic lysosome biogenesis facilitates Abeta clearance and attenuates amyloid plaque pathogenesis. J Neurosci 34, 9607-9620.
27. Yang, D. S., Stavrides, P., Saito, M., Kumar, A., Rodriguez-Navarro, J. A., Pawlik, M., et al. (2014). Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: Prevention by correcting lysosomal proteolytic deficits. Brain 137, 3300-3318.
28. Zhao, T., Huang, X., Han, L., Wang, X., Cheng, H., Zhao, Y., et al. (2012). Central role of mitofusin 2 in autophagosome-lysosome fusion in cardiomyocytes. J Biol Chem 287, 23615-23625.
29. Zhou, J., Tan, S. H., Nicolas, V., Bauvy, C., Yang, N. D., Zhang, J., et al. (2013). Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosomelysosome fusion. Cell Res 23, 508-523.
30. Zhu, X., Chen, C., Ye, D., Guan, D., Ye, L., Jin, J., et al. (2012). Diammonium glycyrrhizinate upregulates PGC-1alpha and protects against Abeta1-42-induced neurotoxicity. PLoS One 7, e35823.